학술논문

Managing Functional and Cognitive Decline in Patients with Mild-to-Moderate Alzheimer's Disease: A 48-Week, Randomized, Double-Blind Evaluation of 13.3 mg/24 h (15 cm(2)) Versus 9.5 mg/24 h (10 cm(2)) Rivastigmine Patch
Document Type
Journal
Source
NEUROLOGY; APR 2012, 78 3p. Supplement: 1
Subject
Language
English
ISSN
00283878